Suppr超能文献

豚鼠肠道和纹状体中5-羟色胺4受体的鉴定与特性分析

Identification and characterization of the 5-HT4 receptor in the intestinal tract and striatum of the guinea pig.

作者信息

Uchiyama-Tsuyuki Y, Saitoh M, Muramatsu M

机构信息

OTC Pharmacology Laboratory, OTC Product R&D Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.

出版信息

Life Sci. 1996;59(25-26):2129-37. doi: 10.1016/s0024-3205(96)00569-3.

Abstract

Receptors for 5-hydroxytryptamine (5-HT) of the 5-HT4 type were investigated in the intestinal tract and the striatum in guinea-pig, in binding studies using the 5-HT4 radioligand, [3H]GR113808. In the intestinal tract, specific binding was observed in preparations of the longitudinal muscle with the myenteric plexus (LMMPs) but not in the whole tissue. Saturable binding of [3H]GR113808 was demonstrated (striatum: Kd = 0.054 +/- 0.002 nM, Bmax = 90.25 +/- 10.44 fmol/mg protein, LMMPs of ileum: Kd = 0.077 +/- 0.016 nM, Bmax = 11.95 +/- 3.24 fmol/mg protein). Selective 5-HT4 receptor agonists and antagonists inhibited binding of [3H]GR113808 with high affinities in LMMPs of the ilcum and which correlated well with their actions on the striatum (r = 0.98), as indicated by the rank order of displacement potencies: SDZ205-557 > LY297524 > cisapride = BIMU8 > 5-HT > mosapride > renzapride > 5-hydroxy-N-methyltryptamine(5-HMT) > (+/-) zacopride > alpha-methyl-5-hydroxytryptamine (alpha-M-5-HT) > 5-methyltryptamine(5-MT) > 5-carboxamidotryptamine (5-CT). The number of binding sites of [3H]GR113808 in the intestine was significantly smaller than that in the brain. In the intestine, a larger number of binding sites was noted in the upper part of the intestine, the rank order being duodenum > jcjunum > ilcum > > colon > rectum. Such data are relevant regarding the potential use of the 5-HT4 receptor ligand to modify motility and secretion in the intestine.

摘要

利用5-HT4放射性配体[3H]GR113808,通过结合研究在豚鼠的肠道和纹状体中对5-HT4型5-羟色胺(5-HT)受体进行了研究。在肠道中,在带有肠肌间神经丛的纵肌制备物(LMMPs)中观察到特异性结合,但在整个组织中未观察到。证明了[3H]GR113808的可饱和结合(纹状体:Kd = 0.054±0.002 nM,Bmax = 90.25±10.44 fmol/mg蛋白质,回肠的LMMPs:Kd = 0.077±0.016 nM,Bmax = 11.95±3.24 fmol/mg蛋白质)。选择性5-HT4受体激动剂和拮抗剂在回肠的LMMPs中以高亲和力抑制[3H]GR113808的结合,这与其对纹状体的作用密切相关(r = 0.98),如取代效力的等级顺序所示:SDZ205-557 > LY297524 > 西沙必利 = BIMU8 > 5-HT > 莫沙必利 > 瑞巴派特 > 5-羟-N-甲基色胺(5-HMT)>(±)扎考必利 > α-甲基-5-羟色胺(α-M-5-HT)> 5-甲基色胺(5-MT)> 5-羧酰胺色胺(5-CT)。肠道中[3H]GR113808的结合位点数量明显少于脑中的。在肠道中,肠道上部的结合位点数量较多,顺序为十二指肠>空肠>回肠>>结肠>直肠。这些数据与5-HT4受体配体在调节肠道运动和分泌方面的潜在用途相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验